Susan Dexter - Jul 11, 2025 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role: Chief Technical Officer
Signature: /s/ Susan Dexter
Stock symbol: SONN
Transactions as of: Jul 11, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/15/2025, 07:35 PM
Previous filing: Dec 5, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dexter Susan	Chief Technical Officer	100 OVERLOOK CENTER,, SUITE 102, PRINCETON,	/s/ Susan Dexter	2025-07-15	0001806764

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SONN	Common Stock	Award		+8K	+486.91%		9.64K	Jul 11, 2025	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 11, 2025, the Reporting Person was granted 8,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan).
F2	Includes unvested restricted stock units.
F3	All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024.